Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Infinity Pharmaceuticals Company Profile (NASDAQ:INFI)

Consensus Ratings for Infinity Pharmaceuticals (NASDAQ:INFI) (?)
Ratings Breakdown: 3 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $18.50 (42.09% upside)

Analysts' Ratings History for Infinity Pharmaceuticals (NASDAQ:INFI)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2015Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015NomuraReiterated RatingNeutral -> Buy$17.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015RBC CapitalReiterated RatingOutperform$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Deutsche BankInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Morgan StanleyDowngradeOverweight -> Equal Weight$19.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Credit SuisseUpgradeNeutral -> Outperform$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2014Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014NomuraBoost Price Target$12.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Jefferies GroupBoost Price TargetBuy$13.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014JMP SecuritiesUpgradeMarket Perform -> Outperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014Roth CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014WedbushUpgradeUnderperform -> Neutral$9.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014William BlairUpgradeOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Morgan StanleyInitiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014WedbushLower Price Target$10.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Stifel NicolausReiterated RatingBuy$25.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$24.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupUpgradeHold -> Buy$15.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014NomuraLower Price Target$17.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014WedbushInitiated CoverageUnderperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2014NomuraBoost Price Target$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2014Jefferies GroupBoost Price Target$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014NomuraInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/12/2013Credit SuisseDowngradeOutperform -> Neutral$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013William BlairInitiated CoverageMarket Perform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2013Morgan StanleyLower Price TargetHold$47.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/5/2013Goldman SachsLower Price TargetNeutral$40.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2013Jefferies GroupLower Price Target$35.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2013Credit SuisseLower Price Target$42.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2013RBC CapitalLower Price Target$55.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)